GlassScriptPhysician profile
James A Schroder
NPI 1770529976
$1,668.68
in general payments reported to CMS, 2019-2025
10 companies · $160 in 2025
The $160 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $495 · 2021: $42.09 · 2022: $478 · 2023: $266 · 2024: $228 · 2025: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $640 · Entertainment: $13.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $640.43 |
| Entertainment | $13.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $658.32 | 2020-2024 | Acrysof Iq Panoptix Uv Iol, Precision 1 |
| Oyster Point Pharma, INC. | $193.36 | 2022-2023 | Tyrvaya |
| Tarsus Pharmaceuticals, INC. | $185.76 | 2024-2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $183.16 | 2022-2024 | Vyzulta, Miebo, Xiidra |
| Optos, INC. | $115.57 | 2022-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Coopervision INC. | $113.33 | 2020-2025 | Paragon Crt, Myday Contact Lens, Misight Contact Lens |
| Johnson & Johnson Vision Care, INC. | $100.55 | 2020-2025 | |
| Allergan, INC. | $60.05 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $35.71 | 2021-2022 | |
| Biotissue Holdings INC. | $22.87 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Schroder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.